June 2025 Targeted Pulse
Catch up on the week's latest oncology news, from clinical trial updates to FDA approvals.
This week in oncology highlights: FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
2
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
3
FDA Grants Priority Review to Subcutaneous Amivantamab for Advanced HNSCC
4
Risvutatug Rezetecan Improves PFS in Phase 3 Osteosarcoma Trial
5